Global Medical and Health Communication
Vol 11, No 3 (2023)

Cytotoxicity of Combination Doxorubicin and Garcinia picrorrhiza Fruit Extract on Fibroblast Cell

Sri Utami (Faculty of Medicine, Universitas YARSI, Central Jakarta)
Susi Endrini (Faculty of Medicine, Universitas YARSI, Central Jakarta)
Lilian Batubara (Faculty of Medicine, Universitas YARSI, Central Jakarta)
Nunung Ainur Rahmah (Faculty of Medicine, Universitas YARSI, Central Jakarta)
Irfan Syarif (Faculty of Medicine, Universitas YARSI, Central Jakarta)
Said Nafik (Directorate General of Intellectual Property, Ministry of Law and Human Rights Republic of Indonesia, South Jakarta)
Betharie Cendera Arrahmani (Risk and Regulatory Consulting Pharma and Life Sciences, PricewaterhouseCoopers (PwC) GmbH WPG, Frankfurt)
Agung Novianto (Biomolecular and Biomedical Research Center, Aretha Medika Utama, Bandung)
Hanna Sari Widya Kusuma (Biomolecular and Biomedical Research Center, Aretha Medika Utama, Bandung)
Wahyu Widowati (Faculty of Medicine, Universitas Kristen Maranatha, Bandung)



Article Info

Publish Date
23 Dec 2023

Abstract

Combining chemotherapeutic agents such as doxorubicin with herbal products or other compounds that can enhance cytotoxicity without side effects is required. Thus, we aimed to observe the cytotoxicity of doxorubicin and sesoot (Garcinia picrorrhiza) fruit ethanolic extract (GpKar) on human fibroblast cells, BJ. This study used a post-test-only control randomized group design with n=3 and a number group of 5. The method used in this research is cell number, and viability was measured with (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay. Treatments consisted of a combination of doxorubicin (0.02 μg/ml) and GpKar of 66.47 µg/ml (DES1), 132.94 µg/ml (DES2) and 265.89 μg/ml (DES3). The data were analyzed using a one-way ANOVA and Duncan post hoc tests. DES3 showed the lowest viability among treatments (89.32%). DES1 and DES2 showed high viability (>90%), 97.93%, and 95.08%, respectively. Thus, the combination of doxorubicin (0.02 μg/ml) and GpKar (66.47 µg/ml) was considered safe for further use in the following assay. In summary, the combination of doxorubicin and GpKar showed high viability in normal fibroblast cells.

Copyrights © 2023






Journal Info

Abbrev

gmhc

Publisher

Subject

Dentistry Health Professions Immunology & microbiology Nursing Public Health

Description

Global Medical and Health Communication is a journal that publishes research articles on medical and health published every 4 (four) months (April, August, and December). Articles are original research that needs to be disseminated and written in English. Subjects suitable for publication include ...